Pharmacotherapy

Papers
(The H4-Index of Pharmacotherapy is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
173
Warfarin dosage in a postpartum woman while breastfeeding: A case report121
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey107
Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or R99
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors95
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy64
Update and narrative review of avian influenza (H5N1) infection in adult patients56
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy54
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps54
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect51
Correlation Between Analgesic and Sedative Drug Withdrawal and Salivary Cortisol Levels in Children in PICUs : A Prospective Cohort Study50
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorse46
A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial43
42
Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”40
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency35
Response to comment on “Dosing implications for liposomal amphotericin B in pregnancy”31
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study30
Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy29
Biomarkers in the intensive care setting: A focus on using procalcitonin and C‐reactive protein to optimize antimicrobial duration of therapy26
Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial26
Factors That Influence Blood Pressure Changes With the Use of Sodium‐Glucose Cotransporter 2 Inhibitors in People With Type 2 Diabetes25
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution25
Pharmacokinetics of Ceftolozane/Tazobactam in Patients With Partial‐ and Full‐Thickness Skin Burns25
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy24
Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation24
Predictors and Clinical Outcomes of Long‐Term Opioid Therapy in Older Adults: A Systematic Review24
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures24
0.16626405715942